Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
UNIDEX-50 is a sterile, hypertonic 50% glucose (dextrose) intravenous infusion manufactured by Unique Pharmaceuticals. It is indicated for fluid replacement without significant electrolyte deficit and for the rapid treatment of severe hypoglycemia (low blood sugar) or hypoglycemic coma. As a concentrated source of carbohydrates, it provides immediate calories and water for hydration, helps reduce the loss of body protein and nitrogen, and promotes glycogen deposition in the liver. Additionally, hypertonic glucose infusions can be used to treat cerebral edema, shock, circulatory collapse, and to correct hyperkalemia when administered in combination with insulin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucose 50% solution.